During the past decade, Wayne State University- Detroit Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wayne State University- Detroit Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials, followed by "Sunovion" with 3 trials sponsored, "Actelion" with 1 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored and "BioMarin Pharmaceutical" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wayne State University- Detroit Medical Center" #1 collaborator was "Cedars-Sinai Medical Center" with 2 trials as a collaborator, "Children's Hospital of Philadelphia" with 2 trials as a collaborator, "Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta" with 2 trials as a collaborator, "Johns Hopkins University" with 2 trials as a collaborator and "King's College Hospital NHS Trust" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Wayne State University- Detroit Medical Center" are "HIV Infections" (10 trials), "Breast Cancer" (2 trials), "Epilepsy" (2 trials), "Mycobacterium Avium-intracellulare Infection" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Wayne State University- Detroit Medical Center" in a lesser frequency.

Most popular intervention types in "Wayne State University- Detroit Medical Center" are "Drug" (15 trials), "Device" (4 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Didanosine" (2 trials), "Efavirenz" (2 trials), "Eslicarbazepine acetate" (2 trials) and "Indinavir sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wayne State University- Detroit Medical Center" are 23 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wayne State University- Detroit Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Wayne State University- Detroit Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wayne State University- Detroit Medical Center, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".